Lack of association between the MTHFR C677T variant and migraine with aura in an older population: Could selective survival play a role?

Cephalalgia

Volumn 33, Issue 5, 2013, Pages 308-315

  Scher, Ann I ^a,b   Eiriksdottir, Gudny ^c   Garcia, Melissa ^b   Feit, Preethy ^a   Smith, Albert V ^c,e   Harris, Tamara B ^b   Roecklein, Kathryn A ^d   Gudmundsson, Larus S ^a,b   Gudnason, Vilmundur ^c,e   Launer, Lenore J ^b  

^a Uniformed Services University of the Health Sciences   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c ICELANDIC HEART ASSOCIATION   (Iceland)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ICELAND   (Iceland)

Author keywords

association studies in genetics; folate; Migraine; MTHFR; selection bias; selective survival

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; ICELAND; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MORTALITY; NONMIGRAINE HEADACHE; SURVIVAL;

AGED; AGED, 80 AND OVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIGRAINE WITH AURA; MUTATION; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84875480532     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102412469739     Document Type: Article

References (49)

1. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am J Epidemiol. 2000 ; 151: 862-877
2. de Bree A, Verschuren WMM, Bjorke-Monsen AL, et al. Effect of the methylenetetrahydrofolate reductase 677C->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr. 2003 ; 77: 687-693
3. Diaz-Arrastia R. Homocysteine and neurologic disease. Arch Neurol. 2000 ; 57: 1422-1427
4. Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 2003 ; 26: 137-146
5. Scher AI, Wu H, Tsao JW, et al. MTHFR C677T genotype as a risk factor for epilepsy including post-traumatic epilepsy in a representative military cohort. J Neurotrauma. 2011 ; 28: 1739-1745
6. Kara I, Sazci A, Ergul E, et al. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res. 2003 ; 111: 84-90
7. Kowa H, Yasui K, Takeshima T, et al. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet. 2000 ; 96: 762-764
8. Lea RA, Ovcaric M, Sundholm J, et al. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med. 2004 ; 2: 3-3
9. Oterino A, Toriello M, Valle N, et al. The relationship between homocysteine and genes of folate-related enzymes in migraine patients. Headache. 2010 ; 50: 99-168
10. Pezzini A, Grassi M, Del ZE, et al. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke. 2007 ; 38: 3145-3151
11. Scher AI, Terwindt GM, Verschuren WM, et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol. 2006 ; 59: 372-375
12. Schürks M, Zee RY, Buring JE, Kurth T. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology. 2008 ; 71: 505-513
13. Todt U, Freudenberg J, Goebel I, et al. MTHFR C677T polymorphism and migraine with aura. Ann Neurol. 2006 ; 60: 621-622
14. Liu A, Menon S, Colson NJ, et al. Analysis of the MTHFR C677T variant with migraine phenotypes. BMC Res Notes. 2010 ; 3: 213-213
15. Tietjen GE, Herial NA, Utley C, et al. Association of von Willebrand factor activity with ACE I/D and MTHFR C677T polymorphisms in migraine. Cephalalgia. 2009 ; 29: 960-968
16. Joshi G, Pradhan S, Mittal B. Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. J Neurol Sci. 2009 ; 277: 133-137
17. Ishii M, Shimizu S, Sakairi Y, et al. MAOA, MTHFR, and TNF-beta genes polymorphisms and personality traits in the pathogenesis of migraine. Mol Cell Biochem. 2012 ; 363: 357-366
18. Samaan Z, Gaysina D, Cohen-Woods S, et al. Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: A case control study and meta-analysis. BMC Neurol. 2011 ; 11: 66-66
19. Ferro A, Castro MJ, Lemos C, et al. The C677T polymorphism in MTHFR is not associated with migraine in Portugal. Disease Markers. 2008 ; 25: 107-113
20. Kaunisto M, Kallela M, Hamalainen E, et al. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia. 2006 ; 26: 1462-1472
21. Maher BH, Griffiths LR. Identification of molecular genetic factors that influence migraine. Mol Genet Genomics. 2011 ; 285: 433-446
22. Schürks M, Rist PM, Kurth T. MTHFR 677C>T and ACE D/I polymorphisms in migraine: A systematic review and meta-analysis. Headache. 2010 ; 50: 588-599
23. Gudmundsson LS, Scher AI, Aspelund T, et al. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: Prospective cohort study. BMJ. 2010 ; 341: c3966 - c3966
24. Yang Q, Bailey L, Clarke R, et al. Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults. Am J Clin Nutr. 2012 ; 95: 1245-1253
25. Anderson CD, Nalls MA, Biffi A, et al. The effect of survival bias on case-control genetic association studies of highly lethal diseases. Circ Cardiovasc Genet. 2011 ; 4: 188-196
26. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med. 1995 ; 122: 96-102
27. Harris TB, Launer LJ, Eiriksdottir G, et al. Age, Gene/environment susceptibility - Reykjavik Study: Multidisciplinary applied phenomics. Am J Epidemiol 2007: kwk115.
28. Qiu C, Cotch MF, Sigurdsson S, et al. Retinal and cerebral microvascular signs and diabetes: The age, gene/environment susceptibility-Reykjavik study. Diabetes. 2008 ; 57: 1645-1650
29. Eiriksdottir G, Aspelund T, Bjarnadottir K, et al. Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study. Atherosclerosis. 2006 ; 186: 222-224
30. Saczynski JS, Jonsdottir MK, Garcia ME, et al. Cognitive impairment: An increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility-Reykjavik study. Am J Epidemiol. 2008 ; 168: 1132-1139
31. Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA. 2006 ; 296: 283-291
32. Liew G, Wang JJ, Mitchell P. Migraine and coronary heart disease mortality: A prospective cohort study. Cephalalgia. 2007 ; 27: 368-371
33. Kurth T, Kase CS, Schurks M, et al. Migraine and risk of haemorrhagic stroke in women: Prospective cohort study. BMJ. 2010 ; 341: c3659 - c3659
34. Schürks M, Rist PM, Shapiro RE, Kurth T. Migraine and mortality: A systematic review and meta-analysis. Cephalalgia. 2011 ; 31: 1301-1314
35. Last JM A dictionary of epidemiology. New York: Oxford University Press ; 1995 :
36. Vineis P, McMichael AJ. Bias and confounding in molecular epidemiological studies: Special considerations. Carcinogenesis. 1998 ; 19: 2063-2067
37. De Bree A, Verschuren WM, Blom HJ, et al. Coronary heart disease mortality, plasma homocysteine, and B-vitamins: A prospective study. Atherosclerosis. 2003 ; 166: 369-377
38. De Bree A, Verschuren WM, Kromhout D, et al. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev. 2002 ; 54: 599-618
39. Holmes MV, Newcombe P, Hubacek JA, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: A meta-analysis of genetic studies and randomised trials. Lancet. 2011 ; 378: 584-594
40. Tsai MY, Loria CM, Cao J, et al. Clinical utility of genotyping the 677C>T variant of methylenetetrahydrofolate reductase in humans is decreased in the post-folic acid fortification era. J Nutr. 2009 ; 139: 33-37
41. Rexrode KM, Lee IM, Cook NR, et al. Baseline characteristics of participants in the Women's Health Study. J Women's Health Gender-based Med. 2000 ; 9: 19-27
42. Schürks M, Zee RY, Buring JE, Kurth T. MTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women. Cephalalgia. 2010 ; 30: 447-456
43. Hessner MJ, Dinauer DM, Kwiatkowski R, et al. Age-dependent prevalence of vascular disease-associated polymorphisms among 2689 volunteer blood donors. Clin Chem. 2001 ; 47: 1879-1884
44. Matsushita S, Muramatsu T, Arai H, et al. The frequency of the methylenetetrahydrofolate reductase-gene mutation varies with age in the normal population. Am J Hum Genet. 1997 ; 61: 1459-1460
45. Brattstrom L, Zhang Y, Hurtig M, et al. A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis. 1998 ; 141: 315-319
46. Galinsky D, Tysoe C, Brayne CE, et al. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis. 1997 ; 129: 177-183
47. Heijmans BT, Gussekloo J, Kluft C, et al. Mortality risk in men is associated with a common mutation in the methylene-tetrahydrofolate reductase gene (MTHFR). Eur J Hum Genet. 1999 ; 7: 197-204
48. Harmon DL, McMaster D, Shields DC, et al. MTHFR thermolabile genotype frequencies and longevity in Northern Ireland. Atherosclerosis. 1997 ; 131: 137-138
49. Faure-Delanef L, Quere I, Chasse JF, et al. Methylenetetrahydrofolate reductase thermolabile variant and human longevity. Am J Hum Genet. 1997 ; 60: 999-1001